H+ transport by the aldosterone-deficient rat distal nephron  by Kornandakieti, Chaleomsri & Tannen, Richard L.
Kidney International, Vol. 25 (1984), pp. 629—635
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H transport by the aldosterone-deficient rat distal nephron. The
effect of aldosterone on distal nephron acidification was investigated by
comparing isolated perfused kidneys from adrenalectomized rats treat-
ed for 3 to 5 days with dexamethasone atone (10 pg/day i.p.) and from
rats given in addition a physiologic dose of d-aldosterone (10 gIday in
oil s.c.). The maximal pH gradient between urine and perfusate,
determined at a perfusate pH of 6.7 with glucose as the sole substrate,
did not differ significantly between the aldosterone deplete and replete
groups (1.27 0.12vs. 1.35 0.12). H secretory capacity of the distal
nephron was determined by perfusing kidneys at pH 6.8 and providing
saturating quantities of urinary buffer in the form of creatinine. Under
these experimental conditions kidneys from aldosterone deplete rats
had a higher urine pH and lower excretion rate of titratable acid
indicative of a defect in H secretion. Acid secretion below a pH of 6.0
(T.A.-pH 6.0), an index of H secretion by the distal nephron, was also
significantly lower in the aldosterone deplete kidneys. Thus, aldoster-
one depletion decreased the H secretory capacity of the distal
nephron, but had no clear effect on the force of the pump as reflected by
the maximal pH gradient. Amiloride (l0— M) was added to the
perfusate of kidneys undergoing the H secretory capacity protocol to
distinguish between sodium-linked and sodium-independent effects of
aldosterone. The difference in T.A. pH 6.0 between aldosterone deplete
and replete kidneys was reduced by approximately 70% in the presence
of amiloride. This indicates that a substantial portion of the aldosterone-
dependent component of distal nephron H secretion is mediated by a
sodium-dependent mechanism.
Transport d'H par le néphron distal de rats déficients en aldostérone.
L'effet de l'aldostérone sur l'acidification du néphron distal a ét étudié
en comparant des reins perfusés isolés provenant de rats surrénaleco-
misés traités pendant 3 a 5jours avec de Ia dexaméthasone seule (10 tg/jour i.p.) et de rats recevant en plus une dose physiologique de
d'aldostérone (10 g/j dans de l'huile s.c.). Le gradient maximum de pH
entre l'unne et le perfusat, déterminé avec un perfusat de pH 6,7 avec
du glucose comme seul substrat, ne différait pas significativement entre
les groupes recevant ou ne recevant pas d'aldostérone (1,27 0,12
contre 1,35 0,12). La capacité sécrétoire d'H du néphron distal a été
déterminée en perfusant les reins a pH 6,8 et en apportant des quantités
saturantes de tampons urinaires sous forme de créatinine. Dans ces
conditions experimentales, les reins de rats déplétés en aldostérone
avaient un pH urinaire plus élevé et un debit d'excrétion d'acidité
titrable plus faible, indiquant un défaut de sécrétion d'Ht La sécrétion
acide pour un pH inférieur a 6,0 (T.A.-pH 6,0), index de sécrétion d'H
par le néphron distal était egalement significativement plus faible dans
les reins dCpletés en aldostérone. Ainsi Ia depletion en aldostérone
diminuait Ia capacitC sécrétoire en H du nephron distal, mais n'avait
pas d'effet clair sur Ia force de Ia pompe, comme Ic reflétait le gradient
de pH maximal. De l'amiloride (l0— M) a été ajouté au perfusat des
reins subissant le protocole de capacité sécrétoire d'H, afin de
distinguer entre les effets de l'aldostérone relies au sodium ou indepen-
dants du sodium. La difference de TA. pH 6,0 entre les reins dCplétés
ou réplétés en aldostérone était réduite d'environ 70% en presence
d'amiloride. Ceci indique qu'une portion substantielle du constituant
dépendant de l'aldostérone de Ia sécrétion H dans Ic nephron distal est
mCdiée par un mécanisme dépendant du sodium.
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Aldosterone affects W transport by the anuran urinary
bladder, an analog of the mammalian collecting duct, by altering
the secretory capacity of the epithelium without modifying the
electrochemical gradient against which H ions can be trans-
ported [1, 2].
Substantial evidence also suggests that aldosterone influ-
ences renal acidification by the mammalian kidney. Mm-
eralocorticoid excess states are accompanied by metabolic
alkalosis and deficiency states by metabolic acidosis, but delin-
eation of the direct effect of aldosterone on H transport, per
Se, in these settings is complicated by changes in K homeosta-
sis, volume status, GFR, the effects of glucocorticoids, and the
possible influence of aldosterone directly on renal ammonia
production [3—20]. Several studies in adrenalectomized rats
point to impaired acidification, but it is not possible to deter-
mine whether aldosterone directly alters H secretion, solely
modifies the transepithelial H gradient, or modifies H secre-
tion indirectly as a consequence of an affect on sodium trans-
port or ammoniagenesis [4, 5, 18—201. A direct effect of mineral-
ocorticoids on both bicarbonate reabsorption and tubular fluid
pH has been demonstrated with the isolated perfused rabbit
collecting duct [21—22].
We have developed a new indirect technique for assessing the
components of distal nephron H secretion by the isolated,
perfused rat kidney [23, 24]. This approach permitted an
examination of acidification by the mineralocorticoid deficient
rat distal nephron independent of the effects of GFR and other
volume-mediated phenomena, and also of altered ammonia
production and buffer excretion. With this technique we delin-
eated a specific effect of mineralocorticoids on H secretion. In
addition, by the use of amiloride, it was possible to determine
whether the effect of aldosterone was mediated by a Nat
dependent process or a direct effect on hydrogen ion transport.
Methods
Adrenalectomized male Sprague-Dawley rats (Charles River
Laboratories, Wilmington, Massachusetts) weighing between
280 and 300 g were started on a steroid placement protocol 2 to
3 days after adrenalectomy. All rats received dexamethasone,
10 g dissolved in water, intraperitoneally daily for 3 to 5 days.
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The control group (aldosterone replete) also received d-aldos-
terone, 10 g in oil subcutaneously, each day; while the
experimental group (aldosterone deplete) was not supplement-
ed with mineralocorticoid. Animals were fed standard rat chow
and received 0.9% saline to drink. No significant difference in
weight gain was detected between the rats which received
aldosterone and those that remained mineralocorticoid deficient
and arterial plasma potassium concentrations determined with a
separate set of animals were not significantly different in the
two groups (4.6 0.2 vs. 4.9 0.2 mM), nor were determina-
tions of total carbon dioxide (26.8 0.5 vs. 26.1 1.1 mM).
After the 3 to 5 days of steroid administration, isolated
kidneys from these animals were perfused in vitro as described
previously with 7.5% albumin Krebs-Henseleit bicarbonate
equilibrated with 95% 02/5% CO2 containing 5 m glucose as
the sole substrate [23—26]. Two basic experimental designs
were used:
(1) Maximal urine pH gradient. Kidneys from aldosterone
deplete (N = 7) and aldosterone replete rats (N = 7) were
perfused for 90 mm at progressively lower perfusate pH (that is,
bicarbonate) values, The perfusate pH was adjusted to 7.1
initially by adding hydrochloric acid and lowered in stepwise
fashion each 20 mm to reach a final perfusate pH of less than 6.8
[24]. Urine and perfusate pH were measured every 10 mm.
(2) Maximal H secretory capacity. Kidneys from aldoster-
one deplete (N = 10) and replete (N = 8) rats were perfused for
90 mm at a constant perfusate pH of 6.8 maintained by
intermittent additions of hydrochloric acid. Creatinine (2 ml of a
0.4 M solution) was added to the perfusate after 30 mm of
perfusion and in stepwise fashion every 15 mm thereafter to
achieve a final excretion rate greater than 30 moles/ml GFR.
Urine samples were collected at 15-mm intervals [24).
After the initial 90-mm period, experiments were continued
for an additional 15 mi Amiloride (10 M) was added to the
perfusate in six of ten aldosterone deplete and four of eight
aldosterone replete studies. The others served as time control
studies.
Analytical methods
Sodium, potassium, ammonia, creatinine, pH, and inulin
clearance, using '4C inulin, were analyzed as described previ-
ously [23, 24, 26].
Calculations
Titratable acid and the amount of acid required to titrate
creatinine from urine pH to pH 6.0 (T.A. pH 6.0) were
calculated from urine pH and creatinine according to the
(Total Cr \formula pH = pk'a + log HCr + 1 using a pK'a
creatinine of 4.91 [251.
The maximal hydrogen ion secretory capacity experiments
were analyzed by examining the relationship between urine pH,
T.A., and T.A. pH 6.0 with creatinine excretion and comparing
the responses of the experimental groups statistically using
profile analysis. Other comparisons were made using paired or
nonpaired Student's t tests.
Results
Maximum pH gradient. Figure 1 compares the pH gradient
between urine and the perfusate of kidneys from adrenalecto-
Perfusate pH
Fig. 1. Effect of aldosterone deficiency on the maximal pH gradient.
Kidneys from aldosterone deplete (open circles) and aldosterone re-
plete (closed circles) rats were subjected to progressive decrements in
perfusate pH by the addition of hydrochloric acid to the perfusate.
Perfusate pH is plotted on the abscissa and the difference between
perfusate and urine pH on the ordinate. The pH gradient between urine
and the perfusate peaked at a perfusate pH of approximately 6.7 and did
not significantly differ at this point between the two groups.
mized (ADX) glucocorticoid-supplemented rats, which either
received aldosterone supplementation daily or were maintained
mineralocorticoid depleted. In prior studies utilizing this tech-
nique of progressive reduction in perfusate pH (that is, bicar-
bonate concentration), a maximal pH gradient was apparent at a
perfusate pH less than 6.89 [24]. The response in the present
studies appeared to follow this trend. Although the largest
gradient achieved was slightly higher in aldosterone replete
group (1.35 0.12 vs. 1.27 0.12), the difference was not
significant statistically. Ammonium excretion did not differ
between the two groups averaging 0.32 0.04 tmoles/min in
the aldosterone replete group and 0.30 0.03 lLmoles/min in the
aldosterone deplete group at the time the maximal pH gradient
was achieved. GFR (0.46 0.09 vs. 0.46 0.04 mI/mm) and
FENa (9 I vs. 10 1%) were similar at the start of perfusion
in the aldosterone replete and deplete groups and remained
comparable for the duration of the experiment.
The maximal pH gradient observed in both the aldosterone
replete and deplete kidneys is substantially lower than the
values we reported previously using kidneys from normal rats
[24]. Additional studies using kidneys from normal rats carried
out concurrently with these ADX experiments demonstrated a
maximal pH gradient comparable to our previous observations.
We have no definitive explanation for the difference in behavior
of adrenalectomized steroid-replaced and normal animals.
Maximal H secretory capacity. The hydrogen ion secretory
capacity of the distal nephron was compared between kidneys
from aldosterone replete and deplete rats using the technique of
stepwise creatinine addition to a perfusate with a low bicarbon-
ate concentration [25]. A detailed examination of this technique
and the analytic methodology employed is described elsewhere
[25].
The acidification data were analyzed by comparing the re-
sponse of the aldosterone replete with aldosterone deplete
group in relation to the quantity of creatinine excreted. The
amounts of creatinine excreted did not differ significantly
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between the two groups. Urine pH was significantly higher at
all levels of creatinine excretion in the aldosterone deplete
kidneys, as shown in Figure 2. Total titratable acid excretion,
shown in Figure 3, was significantly lower in the aldosterone
deficient group. Ammonium excretion, given in Table 1, was
similar in the two groups.
The amount of hydrogen ion required to lower urine from pH
6.0 to the measured value, designated as T.A. pH 6.0, is an
index of hydrogen ion secretion by the distal nephron [24]. As
shown in Figure 4, T.A. pH 6.0 exhibited saturation kinetics in
both the aldosterone deplete and replete group, suggesting that
creatinine delivery was sufficient to saturate distal nephron
hydrogen ion secretion. T.A. pH 6.0 was significantly lower in
the aldosterone deplete group.
Renal functional parameters at the start and completion of
perfusion are provided in Table 1 for both the aldosterone
deplete and replete groups. The intervening values are not
provided; however, comparisons between the two groups were
similar at these times also. As shown in Table 1, perfusate pH,
GFR, urine flow rate, and FENa were similar with the aldoster-
one deplete and replete kidneys. FEK was greater in the
aldosterone replete group. Initial perfusate K concentrations
were similar; and although the final concentration was lower in
the aldosterone replete group, this difference was not significant
statistically.
Acidification parameters (urine pH, titratable acid, and titrat-
able acid to pH 6.0), as well as FEK, were similar with perfused
kidneys from aldosterone replete rats and those obtained from
normal control rats (see [24]). These parameters were signifi-
cantly different in kidneys from aldosterone deplete rats from
normal control rats as well as from the adrenalectomized,
aldosterone supplemented group. This suggests that the aldos-
terone replacement dose was in the physiologic range and that
the aldosterone deplete rats were mineralocorticoid deficient.
To examine the mechanism underlying the apparent differ-
ence in distal nephron hydrogen ion secretion between the
aldosterone deplete and replete kidneys, amiloride (10—i M) was
used to inhibit sodium transport by the distal nephron. To
examine the response to amiloride, perfusions were continued
for an additional 15 mm and stable, high rates of creatinine
excretion were maintained. As shown in Figure 5, urinary pH,
T.A. and T.A. pH 6.0 remain stable when perfusions are
extended from 90 to 105 mm without the addition of amiloride.
In a separate set of studies, amiloride was added to the
perfusate at 90 mm and the control collection at 90 and
experimental collections at 105 mm were compared. Figure 6
shows that amiloride dramatically decreased fractional K
excretion in the aldosterone replete (120 22 to 34 4%, P <
0.025) and deplete kidneys (93 9 to 30 3%, P < 0.01) and
increased urine pH (5.75 0.03 to 5.93 0.02, P < 0.001 and
5.85 0.04 to 5.98 0.04, P < 0.001), respectively. T.A.
decreased from 4.6 0.3 to 3.2 0.2 xmoles/ml GFR, P <
0.01, in the aldosterone replete group and from 3.1 0.4 to 2.4
0.3, P < 0.01 , in the aldosterone deplete group. Ammonium
excretion, given in Table 2, was decreased significantly in the
aldosterone replete group and by a similar amount, but not
significantly, in the deplete group.
The response of T.A. pH 6.0 to amiloride is given in Figure 7.
As shown in the top panel, T.A. pH 6.0 was decreased from
2.08 0.19 to 0.51 0.15 jmoles/ml GFR, P < 0.001 in the
aldosterone replete group and from 1.0 0.30 to 0.18 0.21
Aldo deplete
Aldo replete
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Fig. 2. Effect of aldosterone deficiency on urine pH of creatinine-loaded
kidneys. Kidneys from aldosterone deplete and replete rats perfused at
pH 6.8 were subjected to progressive increases in urinary creatinine
excretion. Urine pH, plotted on the ordinate, was analyzed in relation
to creatinine excretion, plotted on the abscissa. Urine pH was higher in
the aldosterone deplete group at every level of creatinine excretion; and
the complete response was significantly different by profile analysis.
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Fig. 3. Effect of aldosterone deficiency on titrable acid excretion. Total
titratable acid, plotted on the ordinate, was analyzed in relation to
creatinine excretion, plotted on the abscissa. Titratable acid excretion
increased progressively concurrent with creatinine excretion in kidneys
from both aldosterone deplete and replete rats without clear evidence of
saturation. When analyzed in relation to creatinine excretion, T.A.
excretion was significantly lower in the aldosterone deplete than replete
group.
moles/ml GFR, P < 0.01 in the aldosterone deplete group. The
lower panel shows the difference in T.A. pH 6.0 between the
aldosterone deplete and replete groups, which should reflect the
aldosterone-dependent increment in hydrogen ion secretion.
This difference was decreased approximately 70% by amiloride
(from 1.1 to 0.3 moles/ml GFR, P < 0.01).
Renal functional parameters both prior to and after amiloride
addition are given in Table 2. Perfusate pH and potassium
concentration, as well as GFR, urine flow rate and FENa
responded to amiloride in similar fashion in both the aldoster-
one deplete and replete groups. It appeared that amiloride
caused an increase in sodium excretion, especially in the
aldosterone replete group even when compared with the re-
sponse of the appropriate time controls.
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other buffers from the tubular fluid would permit an assessment
of the maximal H gradient the distal nephron epithelium can
achieve and should represent a measure of the force of the W
pump. Phosphate excretion by the isolated perfused kidney is
very low, but ammonium excretion is not completely eradicated
with this technique despite the absence of glutamine from the
perfusate. Nevertheless, with a relatively constrained amount
of buffer excretion, the maximum pH gradient probably more
closely reflects the force of the proton pump than the H
secretory capacity of the epithelium. In the present studies no
significant difference in maximal pH gradient was discerned
between the aldosterone-replaced and deficient kidneys. This
observation is consistent with some observations in humans
and animals with adrenal insufficiency, which indicate that
urine pH can decrease normally [12, 181, and with the findings
in turtle bladders that aldosterone has no influence on the force
of the H pump [1].
To examine the effect of aldosterone on distal nephron H +
secretory capacity, kidneys were perfused at a low pH to
erradicate distal bicarbonate delivery as a significant variable.
H + secretory capacity was examined by providing an abun-
dance of urinary buffer. Creatinine was chosen because it is
nontoxic and has a low pk'a, which is advantageous for
studying distal nephron H secretion. We discuss the advan-
tages and pitfalls of this technique, and its validation, in detail
elsewhere [24]. In essence, by perfusing in the absence of
glutamine the effect of alterations in ammonia production are
minimized, and by perfusing at a low bicarbonate concentra-
tion, the influence of distal bicarbonate reabsorption is mini-
mized. Under these conditions the quantity of H required to
titrate urinary buffer, exogenously provided as creatinine, from
urine pH to pH 6.0 is an indirect indicator of distal nephron H
secretion. By utilizing acid secretion below a pH of 6.0, a
functional, rather than anatomic, segment of the distal nephron
is defined. The assertion that urine acidification below pH 6.0
represents a distal nephron event is supported by the data from
in vivo micropuncture studies that the pH of tubular fluid in the
distal convoluted tubule exceeds 6.0. More direct validation is
provided by the observation in the current study that urine pH
averaged 5.98 when kidneys from aldosterone deplete animals
were perfused in the presence of amiloride. Since both these
maneuvers selectively inhibit acidification at distal nephron
__________________________________________________________
sites, it seems clear that H secretion below pH 6.0 by this
preparation represents a distal nephron event.
When distal nephron H ÷ secretion is compared under differ-
ent experimental conditions, T.A.-pH 6.0 can be used as a valid
index so long as bicarbonate delivery to the distal nephron is
similar. The perfused kidney technique was designed with the
use of a low perfusate bicarbonate concentration to severely
limit the filtered load presented to the proximal nephron for
reabsorption and thereby ensure this condition. Most evidence
indicates that aldosterone selectively influences transport pro-
cesses at distal nephron sites [3]; and the bicarbonate reabsorp-
tive capacity of the intact kidney is not altered in aldosterone
deficient animals further indicating that mineralocorticoids do
not affect bicarbonate reabsorption by the proximal nephron
[13, 18]. In view of the low bicarbonate concentration present in
the perfusate and the evidence that aldosterone does not
influence bicarbonate reabsorption by the proximal nephron, it
seems highly likely that bicarbonate delivery to the distal
3.0
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1.0
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P < 0.05
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Fig. 4. Effect of aldosterone deficiency on T.A.-pH 6.0. T.A.-pH 6.0,
plotted on the ordinate, reflects the amount of titratable acid secreted
below a pH of 6.0 and serves as an index of distal nephron H
secretion. When analyzed in relation to creatinine excretion, shown on
the abscissa, the secretion rate follows saturation kinetics in kidneys
from both aldosterone deplete and replete rats, indicating that creati-
nine delivery is sufficient to saturate the distal H secretory capacity.
In addition, T.A.-pH 6.0 is significantly lower in the aldosterone deplete
group.
Table 1. H+ secretory capacity experiments renal functional
parametersa
Period
Aldosterone
replete
Aldosterone
deplete P
Kidney, wi g 0.25 0.01 0.23 0.01 NS
Perfusate pH Initial
Final
6.83 0.01
6.82 0.01
6.81 0.01
6.82 0.01
NS
NS
Perfusate K,
m
Initial
Final
4.78 0.06
3.63 0.22
4.83 0.06
4.14 0.10
NS
NS
GFR, mi/mm Initial
Final
0.54 0.03
0.39 0.02
0.55 0.02
0.41 0.02
NS
NS
V/GFR Initial
Final
0.26 0.01
0.47 0.02
0.27 0.02
0.47 0.01
NS
NS
FENa, % Initial
Final
15 1
27 2
17 I
28 1
NS
NS
FEK, % Initial
Final
74 10
145 21
57 7
100 6
NS
NS
NH4 excretion,
/.Lmoles/ml
GFR
Initial
Final
0.53 0.07
0.72 0.12
0.54 0.05
0.79 0.13
NS
NS
a The initial period represents the first urine collection after the
addition of creatinine to the perfusate, which is the time period from 30
to 45 mm of perfusion.
Discussion
The initial goal of these studies was to determine whether
aldosterone directly affects distal nephron acidification either
by modifying the force of the H pump or by altering the
secretory capacity.
To examine its effects on the force of the pump, the isolated
perfused kidney technique for assessing maximal H gradients
was used [23]. As described previously, if perfusate bicarbonate
concentration is reduced sufficiently, bicarbonate delivery to
the distal nephron is no longer a significant variable determining
the final urine pH. Under these conditions, elimination of all
Fig. S. Comparison of urinary acid{fication at
90 and 105 mm of perfusion. Perfusions were
extended from 90 to 105 mm and high, but
comparable, rates of creatinine excretion were
maintained. Kidneys from aldosterone replete
rats are shown as closed circles and from
aldosterone deplete rats as open circles. Urine
pH, T.A., and T.A.-pH 6.0 were not different
at 105 as compared with 90 mm in either
group.
Fig. 6. Effect of amiloride on FEK and urine
pH. Amiloride (l0—) was added to the
perfusate at 90 mm, and perfusion continued
for an additional 15 mm with comparable rates
of creatinine excretion. Fractional excretion of
potassium (FEK) is shown on the left and
urine pH on the right prior to and following
the addition of amiloride. Amiloride decreased
FEK and increased urine pH significantly in
both the aldosterone replete and deplete
groups.
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nephron was comparable under the aldosterone deplete and
replete conditions.
Aldosterone deficiency increased urine pH and decreased
total titratable acid excretion by the isolated perfused kidney
with a surfeit of urinary buffer. Thus, the absence of mm-
eralocorticoid clearly impaired the overall H4 secretory capaci-
ty of the kidney. Aldosterone depletion also resulted in a
substantial decrease in T.A.-pH 6.0. In view of the foregoing
discussion it seems clear that the acidification abnormality
selectively reflects a decrease in distal nephron H secretory
capacity. It should be noted that T.A. pH 6.0 exhibited satura-
tion kinetics in both the aldosterone deplete and replete studies,
indicating that maximal rates of H secretion were assessed.
Thus, as in anuran membranes, aldosterone has an effect on the
capacity for W secretion by the epithelium [11. By analogy, it
could affect the number of proton pump units.
It is important to emphasize that this selective decrease in
distal nephron H + secretion by the aldosterone deficient kidney
cannot be explained by alterations in GFR, nor by changes in
sodium delivery to the distal nephron. GFR, FENa, and V/GFR
were similar in the aldosterone deplete and replete kidneys. In
addition, use of the isolated perfused organ eliminates other
potential volume-mediated events. Use of the perfused kidney
also clearly defines a defect in H excretion independent of any
direct or indirect effects of aldosterone depletion on the capaci-
ty for renal ammonia formation. Our data would seem to
conflict with the finding that aldosterone deficiency has no
effect on the Pco2 gradient between urine and blood, an indirect
indicator of distal nephron acidification [14, 18]. Despite the
obvious differences between this technique and the perfused
kidney, one important consideration is that our technique
measures H secretion into an acid urine, while the Pco2
technique indirectly and qualitatively reflects bicarbonate reab-
sorption by the distal nephron. Alternatively, the recent obser-
vation that aldosterone can increase U-B Pco2 in the rabbit
raises the possibility of experimental pitfalls in the studies of
adrenal insufficiency [27]. We cannot resolve the discrepancy,
but believe that our positive results with a more quantitative
technique are likely to be valid.
Thus, aldosterone deficiency, per se, modifies the W trans-
port system of the mammalian distal nephron. The influence of
aldosterone on H secretion by anuran membranes has been
found to be sodium-independent [1]. However, these studies
were performed under voltage clamped conditions and there is
considerable evidence that voltage can also influence H
transport by this preparation [1, 28]. Since in the intact kidney
aldosterone modifies distal nephron Na transport and trans-
epithelial voltage [29—31], its effects on H + transport could be
due either to a direct effect on the H pump and/or to a Nat
voltage-dependent mechanism. To examine this question, we
used amiloride as a probe to block Na, presumably voltage,
dependent H transport.
Both aldosterone deplete and replete kidneys were studied in
the absence as well as the presence of amiloride. Amiloride
increased urine pH and decreased T.A. pH 6.0 in both the
aldosterone deplete and replete kidneys, indicating that some
portion of H secretion under both conditions is Natdepen
dent (Figs. 6 and 7). The data with aldosterone deplete kidneys
clearly demonstrate that a substantial portion of distal nephron
H secretion is by an aldosterone-independent, sodium-linked
mechanism.
In Figure 7, the difference in H secretion between the
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Table 2. Amiloride experiments renal functional parameters
Aldosterone replete
P
Aldosterone deplete
Preamiloride Postamiloride Preamiloride Postamiloride P
Perfusate pH 6.83 0.01 6.84 0.01 NS 6.83 0.01 6.81 0.01 NS
Perfusate K, mw 3.95 0.30 3.99 0.28 NS 4.16 0.13 4.15 0.14 NS
GFR, mi/mm 0.41 0.02 0.40 0.01 NS 0.41 0.02 0.38 0.03 NS
FENa, % 25 4 32 4 0.001 29 1 36 3 NS
V/GFR 0.46 0.02 0,48 0.03 NS 0.44 0.02 0.49 0.03 NS
NH4, p.moles/ml GFR 0.91 0.15 0.66 0.15 0.01 0.82 0.2 0.68 0.19 NS
Urine creatinine, moles/ml GFR 40.3 4 42.1 2.9 NS 33.0 1.4 35.3 2 NS
Fig. 7. Effect of amiloride on T.A.-pH 6.0. The protocol used is
described in Figure 6. The upper panel shows the response of T.A.-pH
6.0 in absolute terms. It decreased significantly with amiloride in both
the aldosterone deplete and replete groups. In the lower panel the
difference in T.A.-pH 6.0 between the aldosterone replete and deplete
groups is shown. The addition of amiloride to the perfusate significantly
decreased this value by approximately 70%.
aldosterone deficient and replete kidneys is analyzed in both the
absence and presence of amiloride. This difference should
reflect the aldosterone-dependent increment in distal nephron
hydrogen ion secretion. Amiloride dramatically reduced this
aldosterone-dependent component by approximately 70%, sug-
gesting that a substantial portion of the aldosterone effect on
distal nephron H secretion is mediated by an amiloride
inhibitable sodium, and presumably voltage, dependent mecha-
nism. This might account, in part, for the adverse effects of
sodium depletion on urine acidification by the intact, mm-
eralocorticoid-deficient rat [18].
Recent studies examining bicarbonate reabsorption by rabbit
inner medullary collecting duct found that aldosterone stimulat-
ed transport by a sodium-independent mechanism [21]. If the
effect of aldosterone is similar in rat and rabbit, and if the
mechanism of bicarbonate reabsorption is the same as H
secretion against a pH gradient, these data would suggest that
the effects of amiloride in our studies occur at a cortical
collecting duct site.
Several caveats are required in interpreting our data. First,
we have studied the difference between normal levels of aldos-
terone and its absence. It should not be assumed that increases
in aldosterone above a normal baseline will necessarily influ-
ence H secretion by an identical, largely Nat-dependent
mechanism. Secondly, distal nephron H secretion appears to
be more complex than the presence of only a H pump. Both a
bicarbonate secretory mechanism and H secretory mechanism
may exist in parallel [32, 33]. Since our studies only determine
net H secretory capacity, that is the difference between two
parallel counteracting pathways, we cannot with certainty
define an effect on one versus the other.
In summary, our data indicate that aldosterone depletion
impairs the capacity of the rat distal nephron to secrete H .
Thiseffect is independent of potassium homeostasis, alterations
in GFR, and changes in ammonia production; and it appears to
largely result from an effect on sodium-dependent hydrogen ion
secretion. This primary defect in hydrogen ion secretion may
play a significant role in the acidosis of mineralocorticoid
deficiency, but its precise quantitative sighnificance cannot be
ascertained in relation to other factors such as alterations in K
homeostasis, volume status, GFR, and possible aldosterone-
mediated alterations in ammonia formation.
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